Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Slippery elm bark (Ulmus rubra) contains 50–60% mucilage composed of mucopolysaccharides—including hexose, pentose, methylpentose, and galacturonic acid residues—that hydrate into a viscous demulcent gel coating mucous membranes, providing mechanical protection and supporting epithelial repair throughout the gastrointestinal and respiratory tracts. The bark also delivers condensed tannins (catechins and procyanidins), flavonoids, and phenolic acids that exert complementary anti-inflammatory and antioxidant effects by scavenging reactive oxygen species and inhibiting pro-inflammatory cytokine cascades.
Reported Benefits (Provisional)
Origin & History
Ulmus rubra, commonly known as Slippery Elm, is a deciduous tree native to Eastern North America, found across the United States and Canada. Its inner bark is highly prized in functional nutrition for its abundant mucilage, which provides significant demulcent properties for digestive and respiratory support.
Research Narrative (Provisional)
While slippery elm has a long history of ethnobotanical use documented by the United States Pharmacopeia (listed 1820–1960) and recognized by the FDA as a safe demulcent for oral health products, controlled clinical trials remain limited. A 2002 open-label pilot study by Langmead et al. examined a combination formula containing slippery elm (alongside other botanicals) in patients with irritable bowel syndrome and reported improvements in bowel frequency and symptom scores, though the individual contribution of slippery elm could not be isolated. The NCBI LiverTox database (National Library of Medicine) notes that slippery elm has no documented cases of clinically apparent liver injury, supporting its general safety profile. Additional in-vitro analyses have confirmed that slippery elm mucilage exhibits significant free radical scavenging activity and anti-inflammatory properties, though larger randomized controlled trials are needed to establish definitive clinical efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Mucilage, tannins, flavonoids, polyphenols, pectin. - Minerals: Calcium, magnesium, potassium.
Reported Mechanism (Provisional)
Slippery elm bark's primary bioactivity derives from its mucopolysaccharide-rich mucilage—composed of galactose, rhamnose, galacturonic acid, and 3-O-methyl galactose residues—which upon hydration forms a thick, adhesive gel that physically coats and shields inflamed or ulcerated mucosal surfaces, reducing contact with irritants and gastric acid while promoting epithelial cell migration and wound repair. The bark's condensed tannins (procyanidins and catechins) cross-link exposed extracellular matrix proteins and mucosal glycoproteins, forming a protective astringent barrier and inhibiting bacterial adhesion. Phenolic compounds including quercetin, kaempferol, and beta-sitosterol modulate inflammation by suppressing NF-κB signaling and reducing the expression of pro-inflammatory mediators such as COX-2, TNF-α, and IL-6, while concurrently scavenging superoxide and hydroxyl radicals via electron donation from their hydroxyl groups. This multi-pathway activity—mechanical protection, astringency, anti-inflammatory modulation, and antioxidant defense—accounts for the broad traditional applications across gastrointestinal, respiratory, and dermatological conditions.
Clinical Narrative (Provisional)
Clinical evidence remains limited, with one small study showing slippery elm in combination with other ingredients increased bowel movement frequency by 20% and improved stool consistency in IBS patients. No large standalone clinical trials exist for slippery elm bark alone. Animal and in vitro studies demonstrate systemic anti-inflammatory effects in porcine gastrointestinal models and dose-dependent ROS reduction in ulcerative colitis mucosal biopsies. The evidence base relies primarily on traditional use and mechanistic studies rather than robust human clinical data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.